aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with the mission to revolutionize disease diagnosis and treatment, Adela leverages innovative genome-wide methylation enrichment technology to develop accessible blood tests for cancer and other high-morbidity conditions. Initially focusing on the entire cancer continuum, Adela aims to enhance detection, diagnosis, and disease management through its scalable platform. This technology was pioneered by Dr. Daniel De Carvalho at the Princess Margaret Cancer Centre, underscoring Adela's commitment to cutting-edge scientific research.
Adela has attracted notable attention from key figures in the medical and biotech fields, including its Chief Scientific Officer, Dr. Daniel De Carvalho. The company has achieved significant milestones in developing a platform that can detect minimal residual disease (MRD) post-surgery, guiding adjuvant treatment, and monitoring for cancer recurrence. Adela's impact lies in its potential to transform cancer care by providing early, accurate, and non-invasive diagnostic options, addressing a critical unmet need in oncology.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Blood Tests
Technology
Biotech
Tags
Healthtech
Model Types
Platform, Software
Revenue Type(s)
Transactional
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Americas
When was Adela founded?
Adela was founded in 2020.
Where is Adela's headquarters located?
Adela's headquarters is located in Mexico City, CMX, MX.
When was Adela's last funding round?
Adela's most recent funding round was for $48M (USD) in September 2023.
How many employees does Adela have?
Adela has 68 employees as of Feb 5, 2024.
How much has Adela raised to-date?
As of July 05, 2023, Adela has raised a total of $108M (USD) since Sep 25, 2023.
Add Comparison
Total Raised to Date
$108M
USD
Last Update Sep 25, 2023
Last Deal Details
$48M
USD
Sep 25, 2023
Series A
Total Employees Over Time
68
As of Feb 2024
Adela Address
Mexico City,
Ciudad de México
Mexico
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts